Web-based Insulin Titration - An Efficacy Study
Primary Purpose
Diabetes Mellitus, Type 2
Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Web-based insulin titration
Sponsored by

About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 2
Eligibility Criteria
Inclusion Criteria:
- Male or female between 18 and 80 years
- Type 2 diabetes mellitus (diagnosed clinically) for ≥ 6 months
- Once daily basal insulin therapy usage
- No restriction on HbA1c or FPG
- BMI < 40 kg/m2
- Ability to read and understand the Dutch language
- Familiarity with the Internet and use of a mobile phone
- Ability and willingness to adhere to the protocol
- Ability and willingness to use a web-based insulin self-titration system
- Confirmed written consent
Exclusion Criteria:
- Type 1 diabetes
- Use of systemic corticosteroid in the last three months
- Recurrent severe hypoglycaemia or hypoglycaemic unawareness
- Active proliferative diabetic retinopathy
- Any clinically significant disease or disorder
- Mental condition rendering the patient unable to understand the nature, scope and possible consequences of the study
- Working in night shifts
Sites / Locations
- Academic Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Web-based insulin titration
Standard care
Arm Description
An online web-based insulin titration algorithm to guide patients in self-titration
Outcomes
Primary Outcome Measures
Mean change in HbA1c
Secondary Outcome Measures
Quality of life and treatment satisfaction
Total contact time with study staff (and the PANDIT system, if applicable)
Proportion of subjects who reach the target of HbA1c < 7.0%
Mean change in fasting plasma glucose
Overall incidence and rate of hypoglycaemia (mild hypoglycaemia, probable hypoglycaemia, severe hypoglycaemia and relative hypoglycaemia)
Frequency of the usage of PANDIT among patients
Detection of important factors for patient compliance to internet-based self-care interventions
Full Information
NCT ID
NCT01715090
First Posted
October 22, 2012
Last Updated
November 19, 2014
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
1. Study Identification
Unique Protocol Identification Number
NCT01715090
Brief Title
Web-based Insulin Titration - An Efficacy Study
Official Title
Web-based Insulin Titration: Improving Diabetes Care in the Netherlands. An Efficacy Study.
Study Type
Interventional
2. Study Status
Record Verification Date
November 2014
Overall Recruitment Status
Completed
Study Start Date
December 2012 (undefined)
Primary Completion Date
June 2014 (Actual)
Study Completion Date
July 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The main objective of the study is to determine whether an intensive web-based titration system, called PANDIT (Patient Assisting Net-based Diabetes Insulin Titration), is effective in improving glycaemic control in patients with diabetes mellitus type 2 using a basal insulin, compared to standard care.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
73 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Web-based insulin titration
Arm Type
Experimental
Arm Description
An online web-based insulin titration algorithm to guide patients in self-titration
Arm Title
Standard care
Arm Type
No Intervention
Intervention Type
Device
Intervention Name(s)
Web-based insulin titration
Other Intervention Name(s)
PANDIT
Primary Outcome Measure Information:
Title
Mean change in HbA1c
Time Frame
Change from baseline after 13 weeks and after 26 weeks
Secondary Outcome Measure Information:
Title
Quality of life and treatment satisfaction
Time Frame
Change from baseline after 13 weeks and after 26 weeks
Title
Total contact time with study staff (and the PANDIT system, if applicable)
Time Frame
After 26 weeks
Title
Proportion of subjects who reach the target of HbA1c < 7.0%
Time Frame
After 26 weeks
Title
Mean change in fasting plasma glucose
Time Frame
Change from baseline after 13 weeks and after 26 weeks
Title
Overall incidence and rate of hypoglycaemia (mild hypoglycaemia, probable hypoglycaemia, severe hypoglycaemia and relative hypoglycaemia)
Time Frame
After 26 weeks
Title
Frequency of the usage of PANDIT among patients
Time Frame
After 26 weeks
Title
Detection of important factors for patient compliance to internet-based self-care interventions
Time Frame
After 26 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or female between 18 and 80 years
Type 2 diabetes mellitus (diagnosed clinically) for ≥ 6 months
Once daily basal insulin therapy usage
No restriction on HbA1c or FPG
BMI < 40 kg/m2
Ability to read and understand the Dutch language
Familiarity with the Internet and use of a mobile phone
Ability and willingness to adhere to the protocol
Ability and willingness to use a web-based insulin self-titration system
Confirmed written consent
Exclusion Criteria:
Type 1 diabetes
Use of systemic corticosteroid in the last three months
Recurrent severe hypoglycaemia or hypoglycaemic unawareness
Active proliferative diabetic retinopathy
Any clinically significant disease or disorder
Mental condition rendering the patient unable to understand the nature, scope and possible consequences of the study
Working in night shifts
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frits Holleman, MD PhD
Organizational Affiliation
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Academic Medical Center
City
Amsterdam
Country
Netherlands
12. IPD Sharing Statement
Citations:
PubMed Identifier
21893723
Citation
Simon AC, Holleman F, Hoekstra JB, De Clercq PA, Lemkes BA, Hermanides J, Peek N. Development of a web-based decision support system for insulin self-titration. Stud Health Technol Inform. 2011;169:103-7.
Results Reference
result
PubMed Identifier
22874288
Citation
Simon AC, Holleman F, Gude WT, Hoekstra JB, Peek N. Safety of a web-based insulin titration system for patients with type 2 diabetes mellitus - pilot study. Stud Health Technol Inform. 2012;180:731-5.
Results Reference
result
PubMed Identifier
22874403
Citation
Gude WT, Simon AC, Peute LW, Holleman F, Hoekstra JB, Peek N, Jaspers MW. Formative usability evaluation of a web-based insulin self-titration system: preliminary results. Stud Health Technol Inform. 2012;180:1209-11.
Results Reference
result
Learn more about this trial
Web-based Insulin Titration - An Efficacy Study
We'll reach out to this number within 24 hrs